Two subsidiaries of Shandong Jincheng Pharmaceutical Group (300233.SZ) have completed the payment of taxes and late fees.
Jincheng Pharmaceuticals (300233.SZ) announced that its controlling subsidiary, Guangdong Jincheng Ginseng Pharmaceutical Co., Ltd. ("Jincheng Ginseng"), and its wholly-owned subsidiary, Guangdong Landu Pharmaceutical Co., Ltd. ("Landu Pharmaceutical"), recently received a "Tax Handling Decision" issued by the Zhongshan City Tax Bureau of the State Administration of Taxation.
According to the tax authority's inspection of the tax situation of Jincheng Ginseng and Landu Pharmaceutical for the years 2017 and 2018, Jincheng Ginseng and Landu Pharmaceutical were required to pay a total of 21.5968 million yuan in back taxes and penalties. As of the date of this announcement, Jincheng Ginseng and Landu Pharmaceutical have paid the taxes and penalties in full.
Shandong Jincheng Pharmaceutical Group (300233.SZ) announced that its holding subsidiary, Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd. ("Jincheng Jinsu"), and its wholly-owned subsidiary, Guangdong Landu Pharmaceutical Co., Ltd. ("Landu Pharmaceutical"), recently received the "Taxation Decision" issued by the Zhongshan City Taxation Bureau of the State Administration of Taxation. According to the tax authorities' inspection of Jincheng Jinsu and Landu Pharmaceutical's tax payment situation for 2017 and 2018, they are required to pay a total of 21.5968 million yuan in overdue taxes and fines. As of the date of this announcement, Jincheng Jinsu and Landu Pharmaceutical have paid the taxes and fines in full.
Related Articles

CAPITAL ENV(03989): Capital Investment provides RMB 61.74 million loan to Xiong'an Capital's inaugural initiative.

SJM Holdings (00880) subsidiary completes acquisition of all shares of The Great World Company Limited.

China Shenhua Energy (601088.SH): Beihai Phase II Unit 4 passes 168-hour trial operation.
CAPITAL ENV(03989): Capital Investment provides RMB 61.74 million loan to Xiong'an Capital's inaugural initiative.

SJM Holdings (00880) subsidiary completes acquisition of all shares of The Great World Company Limited.

China Shenhua Energy (601088.SH): Beihai Phase II Unit 4 passes 168-hour trial operation.

RECOMMEND

Not Just “Power Shortages,” Delays Will Become The Key Theme For U.S. Data Centers In 2026
26/12/2025

Hang Seng Index Rises 33% This Year, Best Five‑Year Performance; Multiple Institutions Forecast Breakthrough Above 30,000 Next Year
26/12/2025

Gold Rally Has Further To Run, JPMorgan Bullish: Prices Could Reach USD 5,055 By Year‑End 2026
26/12/2025


